Literature DB >> 20606732

CD44 and p53 immunoexpression patterns in NF1 neoplasms - indicators of malignancy and infiltration.

Nicole D Riddle1, Lemuel Gorden, Mumtaz V Rojiani, Ardeshir Hakam, Amyn M Rojiani.   

Abstract

Neurofibromatosis type 1 (NF1) provides a unique system to evaluate the complete range of neoplastic expressions, from encapsulated benignity to invasiveness and malignancy. This study was aimed at determining whether CD44 and p53 may serve as indicators of malignant progression of neurofibroma. CD44, a transmembrane glycoprotein receptor for hyaluronic acid, and participates in cell-extracellular matrix interactions and migration. CD44 may play a vital role, either through under or overexpression, with invasion and metastases of tumors, altering their ability to infiltrate the adjacent tissue. The tumor suppressor gene, p53, has also been implicated in malignant progression of various human tumors including malignant peripheral nerve sheath tumors (MPNST). A total of 44 tumors from 33 patients with NF1 were evaluated with an anti-human CD44H, CD44 splice variant v6 and anti-p53 monoclonal antibodies. Morphologic expression patterns of expression were evaluated for CD44 while semiquantitative criteria were applied to assess, p53 nuclear positivity. Immunoexpression of p53 was markedly higher in 12 of 16 MPNST (75%). Thirteen of 28 (46%) benign neurofibroma also had some expression of p53 above 'normal level', although much lower than the MPNST. Plexiform neurofibroma did not differ from other benign lesions in their expression of p53. Our results suggest that p53 mutation as evidenced by immunohistochemical overexpression is a factor in malignant transformation and progression of neurofibroma. 70% of benign neurofibroma demonstrated some, usually focal, CD44 positivity. The pattern of CD44 expression in plexiform neurofibroma was revealing, as it was maximal in the 'nonencapsulated' portions of the tumors. Eight of 11 (72%) locally infiltrative cutaneous neurofibroma and 13 of 16 (81%) MPNST exhibited diffuse CD44 positivity. CD44v6 expression was positive in control tissues but was not identified in any of tumor samples. Also, within the confines of encapsulated tumors CD44 expression is limited, while in poorly circumscribed neurofibroma CD44 expression is upregulated. This is interpreted as a reflection of the interaction of CD44+ tumor cells with extracellular matrix, hence facilitating infiltrative behavior.

Entities:  

Keywords:  CD44; Neurofibromatosis type 1 (NF1); immunohistochemistry; infiltration; p53; tumor markers

Mesh:

Substances:

Year:  2010        PMID: 20606732      PMCID: PMC2897111     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  46 in total

1.  Expression patterns of cell cycle components in sporadic and neurofibromatosis type 1-related malignant peripheral nerve sheath tumors.

Authors:  Trude Holmeide Agesen; Vivi Ann Flørenes; Willemina M Molenaar; Guro E Lind; Jeanne-Marie Berner; Boudewijn E C Plaat; Rudy Komdeur; Ola Myklebost; Eva van den Berg; Ragnhild A Lothe
Journal:  J Neuropathol Exp Neurol       Date:  2005-01       Impact factor: 3.685

Review 2.  Expression of the CD44 adhesion molecule in tumours of the central and peripheral nervous system.

Authors:  G H Baltuch; N de Tribolet; E G Van Meir
Journal:  J Neurooncol       Date:  1995-12       Impact factor: 4.130

3.  Rb and TP53 pathway alterations in sporadic and NF1-related malignant peripheral nerve sheath tumors.

Authors:  S Birindelli; F Perrone; M Oggionni; C Lavarino; B Pasini; B Vergani; G N Ranzani; M A Pierotti; S Pilotti
Journal:  Lab Invest       Date:  2001-06       Impact factor: 5.662

4.  Malignant peripheral nerve sheath tumours in neurofibromatosis 1.

Authors:  D G R Evans; M E Baser; J McGaughran; S Sharif; E Howard; A Moran
Journal:  J Med Genet       Date:  2002-05       Impact factor: 6.318

5.  Identification of intronic point mutations as an alternative mechanism for p53 inactivation in lung cancer.

Authors:  T Takahashi; D D'Amico; I Chiba; D L Buchhagen; J D Minna
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

6.  Hyaluronan-CD44 Interactions in Cancer: Paradoxes and Possibilities.

Authors:  Bryan P Toole
Journal:  Clin Cancer Res       Date:  2009-12-15       Impact factor: 12.531

7.  Malignant peripheral nerve sheath tumor cell invasion is facilitated by Src and aberrant CD44 expression.

Authors:  Weiping Su; Mihaela Sin; Andrea Darrow; Larry S Sherman
Journal:  Glia       Date:  2003-06       Impact factor: 7.452

8.  Identification of p53 as a strong predictor of survival for patients with malignant peripheral nerve sheath tumors.

Authors:  Helge R Brekke; Matthias Kolberg; Rolf I Skotheim; Kirsten S Hall; Bodil Bjerkehagen; Björn Risberg; Henryk A Domanski; Nils Mandahl; Knut Liestøl; Sigbjørn Smeland; Håvard E Danielsen; Fredrik Mertens; Ragnhild A Lothe
Journal:  Neuro Oncol       Date:  2009-01-30       Impact factor: 12.300

9.  Systematic assessment of the prognostic impact of membranous CD44v6 protein expression in colorectal cancer.

Authors:  Inti Zlobec; Ursula Günthert; Luigi Tornillo; Giandomenica Iezzi; Daniel Baumhoer; Luigi Terracciano; Alessandro Lugli
Journal:  Histopathology       Date:  2009-11       Impact factor: 5.087

10.  Increased expression of mutant forms of p53 oncogene in primary lung cancer.

Authors:  R Iggo; K Gatter; J Bartek; D Lane; A L Harris
Journal:  Lancet       Date:  1990-03-24       Impact factor: 79.321

View more
  6 in total

1.  Whole Exome Sequencing Reveals the Order of Genetic Changes during Malignant Transformation and Metastasis in a Single Patient with NF1-plexiform Neurofibroma.

Authors:  Angela C Hirbe; Sonika Dahiya; Christopher A Miller; Tiandao Li; Robert S Fulton; Xiaochun Zhang; Sandra McDonald; Katherine DeSchryver; Eric J Duncavage; Jessica Walrath; Karlyne M Reilly; Haley J Abel; Melike Pekmezci; Arie Perry; Timothy J Ley; David H Gutmann
Journal:  Clin Cancer Res       Date:  2015-04-29       Impact factor: 12.531

2.  An isolated neurofibromal polyp of the colon.

Authors:  Pierre Hindy; Russell Parvin; Kayane Hanna; Sherif Andrawes; Frank Gress; Adam Goodman
Journal:  Case Rep Gastroenterol       Date:  2012-01-28

3.  Simultaneous inhibition of cell-cycle, proliferation, survival, metastatic pathways and induction of apoptosis in breast cancer cells by a phytochemical super-cocktail: genes that underpin its mode of action.

Authors:  Allal Ouhtit; Rajiv Lochan Gaur; Mohamed Abdraboh; Shubha K Ireland; Prakash N Rao; Shailaja G Raj; Hamad Al-Riyami; Somya Shanmuganathan; Ishita Gupta; Subramanyam N Murthy; Andrew Hollenbach; Madhwa Hg Raj
Journal:  J Cancer       Date:  2013-11-14       Impact factor: 4.207

4.  Spatially- and temporally-controlled postnatal p53 knockdown cooperates with embryonic Schwann cell precursor Nf1 gene loss to promote malignant peripheral nerve sheath tumor formation.

Authors:  Angela C Hirbe; Sonika Dahiya; Dinorah Friedmann-Morvinski; Inder M Verma; D Wade Clapp; David H Gutmann
Journal:  Oncotarget       Date:  2016-02-16

5.  Incidental finding of isolated colonic neurofibroma.

Authors:  Haritha Chelimilla; Chaitanya K Chandrala; Masooma Niazi; Kavitha Kumbum
Journal:  Case Rep Gastroenterol       Date:  2013-09-05

Review 6.  Cutaneous neurofibromas in the genomics era: current understanding and open questions.

Authors:  Robert J Allaway; Sara J C Gosline; Salvatore La Rosa; Pamela Knight; Annette Bakker; Justin Guinney; Lu Q Le
Journal:  Br J Cancer       Date:  2018-04-26       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.